Indian markets look set for a steady start today after yesterday's recovery snapped a seven-day losing streak. Investors are monitoring key business updates from Tata Motors, Mankind Pharma, and Tata Power, while balancing these developments against global inflation concerns and rising oil prices.
Indian equity markets are showing signs of stability as trading opens on Friday, August 21, 2026. The domestic indices are coming off a positive session on Thursday, which helped end a seven-day decline for the benchmark BSE Sensex and NSE Nifty. While sentiment has improved, investors remain cautious due to persistent global pressure, including elevated crude oil prices and volatility in international bond markets.
Global cues continue to influence the direction of the markets. Rising US Treasury yields and geopolitical tensions in the Middle East have made investors wary of riskier assets. High oil prices, in particular, remain a significant concern for the Indian market, as they can lead to inflation and put pressure on the profit margins of companies that rely heavily on energy or fuel-based raw materials.
Key Corporate Developments
Several companies have announced strategic moves that are attracting attention. Tata Motors is expanding its footprint in the electric vehicle space through a new agreement with the leasing platform Drivn. This partnership aims to deploy over 1,000 electric trucks, signaling the company's intent to strengthen its position in the commercial electric vehicle market. For investors, the success of such initiatives often depends on how effectively the company can manage the capital required for leasing and fleet management.
In the pharmaceutical sector, Mankind Pharma has signed an exclusive in-licensing deal with China's Chongqing Chenan Biopharmaceutical. This agreement allows Mankind to bring specific insulin analogues to the Indian market. While this is a significant step toward diversifying the company’s product portfolio, investors should note that biosimilar and insulin products often face stringent regulatory approval processes that can impact the timeline for commercial launch.
Tata Power Renewable Energy is also in the spotlight, having launched a major 'Har Ghar Solar' initiative in Bihar. The company aims to reach five lakh households over the next three years. Such large-scale government-backed projects offer steady long-term revenue, but they also require consistent execution to avoid delays and cost overruns.
Coal India Limited is taking a strategic approach to diversification by establishing an overseas office in Singapore. The move is designed to help the company secure critical mineral assets, such as lithium, copper, and nickel, which are essential for the energy transition. Additionally, DEE Development Engineers has secured a ₹36 crore pipe-shop fabrication contract from Reliance Industries. This order provides clear short-term revenue visibility, as it is slated for completion within nine months.
What Investors Should Monitor
Moving forward, the primary factor to watch will be the balance between corporate execution and macro-economic stability. While companies are securing new orders and expanding their portfolios, the broader market remains sensitive to global inflation data and interest rate signals. Investors may want to track how these companies manage their operational costs, particularly as global supply-side pressures persist. Any updates on the timeline for projects like Tata Power’s solar initiative or regulatory progress for Mankind Pharma’s new insulin products will be important to follow in the coming quarters.